{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T04:25:55Z","timestamp":1773375955543,"version":"3.50.1"},"reference-count":25,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,3,19]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Cerebral amyloid angiopathy (CAA) is a common, yet frequently underdiagnosed pathology characterised by accumulation of amyloid \u03b2 proteins in the small blood vessels of the brain. As a result, cerebrovascular dysregulation follows, leading to cerebral microbleeds, lobar intracerebral haematomas and sulcal subarachnoid haemorrhages. Gradual motor and cognitive decline due to these brain injuries leads to significant functional limitation in patients. We describe the case of a 69-year-old man requiring multiple hospital admissions with a variety of neurological symptoms. Following imaging of the brain, he was eventually diagnosed with CAA. We present a brief up-to-date literature review on epidemiology, pathophysiology, clinical features, diagnosis and treatment options for CAA.<\/jats:p>","DOI":"10.1136\/bcr-2020-235949","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T13:21:12Z","timestamp":1617801672000},"page":"e235949","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Cerebral amyloid angiopathy: an underdiagnosed cause of recurrent neurological symptoms"],"prefix":"10.1136","volume":"14","author":[{"given":"Fakharunisa","family":"Shah","sequence":"first","affiliation":[{"name":"General Practitioner, Holland House Surgery, Lytham St Annes, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayda","family":"Yazdani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"I'anson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahir","family":"Nazir","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Sciences, Department of Biomolecular Science, University of Manchester Institute of Science and Technology, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"2025082712114426000_14.4.e235949.1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301308"},{"key":"2025082712114426000_14.4.e235949.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2990.2010.01137.x"},{"key":"2025082712114426000_14.4.e235949.3","first-page":"268","article-title":"High prevalence of cerebral amyloid angiopathy (CAA) at post-mortem examination in elderly stroke service patients","volume":"181","author":"Crowe","year":"2012","journal-title":"Irish J Med Sciences"},{"key":"2025082712114426000_14.4.e235949.4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bpa.12629","article-title":"The association between hypertensive arteriopathy and cerebral amyloid angiopathy in spontaneously hypertensive stroke-prone rats","volume":"28","author":"Jandke","year":"2018","journal-title":"Brain Pathology"},{"key":"2025082712114426000_14.4.e235949.5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.4.537"},{"key":"2025082712114426000_14.4.e235949.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.07.724"},{"key":"2025082712114426000_14.4.e235949.7","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2011.93"},{"key":"2025082712114426000_14.4.e235949.8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314697"},{"key":"2025082712114426000_14.4.e235949.9","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A0783"},{"key":"2025082712114426000_14.4.e235949.10","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1212\/WNL.0000000000003197","article-title":"Pet to diagnose cerebral amyloid angiopathy: a prospective study","volume":"87","author":"Gurol","year":"2016","journal-title":"Neurology"},{"key":"2025082712114426000_14.4.e235949.11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21694"},{"key":"2025082712114426000_14.4.e235949.12","first-page":"0481","article-title":"CSF levels of amyloid predict mortality om Alzheimer\u2019s diaease","volume":"11","author":"Boumenir","year":"2019","journal-title":"Alzheimer\u2019s Res Therapy"},{"key":"2025082712114426000_14.4.e235949.13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s13760-017-0816-5","article-title":"Alzheimer\u2019s disease CSF biomarkers: clinical indications and rational use","volume":"117","author":"Niemantsverdriet","year":"2017","journal-title":"Acta Neurol Belg"},{"key":"2025082712114426000_14.4.e235949.14","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.1.148"},{"key":"2025082712114426000_14.4.e235949.15","doi-asserted-by":"publisher","DOI":"10.1159\/000088665"},{"key":"2025082712114426000_14.4.e235949.16","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.563932"},{"key":"2025082712114426000_14.4.e235949.17","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2015-312736"},{"key":"2025082712114426000_14.4.e235949.18","doi-asserted-by":"publisher","DOI":"10.1111\/ijs.12624"},{"key":"2025082712114426000_14.4.e235949.19","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000078311.18928.16"},{"key":"2025082712114426000_14.4.e235949.20","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181eee40f"},{"key":"2025082712114426000_14.4.e235949.21","first-page":"37","article-title":"Cerebral amyloid angiopathy in stroke medicine","volume":"114","author":"Block","year":"2017","journal-title":"Dtsch Arztebl Int"},{"key":"2025082712114426000_14.4.e235949.22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000359","article-title":"Clopidogrel use is associated with an increased prevalence of cerebral microbleeds in a Stroke\u2010Free population: the Rotterdam study","volume":"2","author":"Darweesh","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2025082712114426000_14.4.e235949.23","doi-asserted-by":"publisher","DOI":"10.1111\/ijs.12050"},{"key":"2025082712114426000_14.4.e235949.24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/acn3.761","article-title":"Immunotherapy with ponezumab for probable cerebral amyloid angiopathy","volume":"6","author":"Leurent","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"2025082712114426000_14.4.e235949.25","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.150202"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-235949","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T19:11:55Z","timestamp":1756321915000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-235949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,7]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bcr-2020-235949"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-235949","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}